About Endospan
Endospan is a company based in Herzliya (Israel) founded in 2009 was acquired by Artivion in May 2026. Endospan has raised $10 million across 1 funding round from investors including Artivion, Haisco Pharmaceutical Group and Sequoia Capital. Endospan offers products and services including NEXUS MULTIBRANCH Aortic Arch Stent Graft System. Endospan operates in a competitive market with competitors including SMT, InspireMD, Vesper Medical, Veryan Medical and Biosensors International, among others.
- Headquarter Herzliya, Israel
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Endospan
Endospan offers a comprehensive portfolio of products and services, including NEXUS MULTIBRANCH Aortic Arch Stent Graft System.
Custom-made stent graft for endovascular repair of aortic arch aneurysms and stroke risk reduction.
People of Endospan
Unlock access to complete
Funding Insights of Endospan
Endospan has successfully raised a total of $10M through 1 strategic funding round. The most recent funding activity was a Series C round of $10 million completed in October 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Endospan
Endospan has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Artivion, Haisco Pharmaceutical Group and Sequoia Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Sequoia Capital is engaged in venture capital investments.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Pharmaceutical products are developed for various therapeutic areas.
|
Locked | Locked | Locked |
Investor details for Endospan
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Endospan
Investment portfolio details for Endospan
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Endospan
Detailed financials for Endospan
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Endospan Comparisons
Peer comparison for Endospan
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Endospan
Endospan operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SMT, InspireMD, Vesper Medical, Veryan Medical and Biosensors International, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
SMT is recognized as a developer of cardiovascular medical devices.
|
|
| Locked | Locked | Locked |
Proprietary stent systems with bio-stable mesh are developed and commercialized.
|
|
| Locked | Locked | Locked |
Venous stent system is developed for deep vein disease treatment.
|
|
| Locked | Locked | Locked |
Three-dimensional vascular stents for peripheral vascular disease are developed.
|
|
| Locked | Locked | Locked |
Products for interventional cardiology and critical care procedures
|
Detailed competitors of Endospan
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Endospan
Complete news archive for Endospan
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Endospan
Endospan was founded in 2009 and raised its 1st funding round 6 years after it was founded.
Endospan is headquartered in Herzliya, Israel. It is registered at Herzliya, Central District, Israel.
Endospan is a funded company, having raised a total of $10M across 1 funding round to date.
Endospan was founded in 2009 in Herzliya, Israel, as a venture capital-backed medical device startup in the cardiovascular sector. An endovascular system for aortic aneurysm repair is being developed at the pre-clinical stage. The Nexus platform is designed to support minimally invasive procedures through real-time aortic insights, incorporating two stent graft systemsHorizon and Nexuswhich remain in clinical development.
Endospan's top competitors include SMT, InspireMD and Vesper Medical.
Endospan offers NEXUS MULTIBRANCH Aortic Arch Stent Graft System.
Endospan has 4 investors. Key investors include Artivion, Haisco Pharmaceutical Group, Sequoia Capital, and Accelmed Ventures.